Transgene Biotek share news, announcements and annual reports
BSE: 526139Healthcare ServicesSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹2.42.
30 Oct: open ₹2.59, high ₹2.59, low ₹2.26
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18 Cr4,238th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.11
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.05
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 43,282
Transgene Biotek share news and announcements
486 announcements, routine notices left out, newest first. Page 10 of 10.
Sep 2011
22 Sep · Setting up of wholly-owned Subsidiary Company
Company has set up a wholly-owned subsidiary Company in Hong Kong by the name "Transgene Biotek HK Ltd.". This is to help Transgene in expanding ....7 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 28, 2011 to September 30, 2011 (both days inclusive) ....
Aug 2011
16 Aug · Results
Jul 2011
11 Jul · Transgene to roll out monetization of technology assets
May 2011
16 May · Results
16 May · Transgene Biotek to commence commercial production of another API - DHA
Apr 2011
25 Apr · Meeting
Members at the Extra Ordinary General Meeting (EGM) of the Company held on April 18, 2011, have given their fresh consent for the allotment ....20 Apr · Transgene Biotek restructuring its operations
Mar 2011
30 Mar · Meeting
An Extra Ordinary General Meeting (EGM) of the members of the Company will be held on April 18, 2011, for obtaining the fresh consent for the ....
Feb 2011
23 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 22, 2011, the Company has allotted 2,500,000 GDRs underlying 25,000,000 ....18 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 18, 2011, has decided to open the issue of GDRs upto USD 40 million on February ....17 Feb · Board Meeting on Feb 18, 2011
Meeting of the Board of Directors of the Company will be held on February 18, 2011 to decide upon the opening of the Issue of GDRs upto USD 40 million.14 Feb · Results
Jan 2011
Dec 2010
27 Dec · Transgene's therapeutic AIDS Vaccine - Novel delivery
Nov 2010
18 Nov · Results
2 Nov · Meeting
Members at the Extra-ordinary General Meeting (EGM) of the Company held on November 01, 2010, have approved as special resolutions unanimously : ....
Oct 2010
1 Oct · Board meeting
Board of Directors of the Company at its meeting held on September 30, 2010, has taken the following decisions: 1. To raise funds for ....
Sep 2010
27 Sep · Board Meeting on Sep 30, 2010
Meeting of the Board of Directors of the Company will be held on September 30, 2010, inter alia, to transact the following: 1. To consider ....15 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 28, 2010 to September 30, 2010 (both days inclusive) ....
Aug 2010
5 Aug · Transgene Biotek to acquire USA based Bio-Pharma company
Jul 2010
31 Jul · Results
19 Jul · Transgene's AIDS Vaccine advances to the next milestone
May 2010
25 May · Transgene files patent on its novel monoclonal antibody (mAb) effective against three cancers
12 May · Transgene's Monoclonal antibody - uniquely effective against three cancers
Apr 2010
27 Apr · Results
26 Apr · Transgene expands the cancer drug pipeline - A novel drug for Colon Cancer
Mar 2010
30 Mar · Develops new cancer drug against Multiple myeloma
22 Mar · Files patents for AIDS vaccine and Multiple Sclerosis drug
3 Mar · Files 2 patents for Liver and Breast Cancer drugs
Feb 2010
22 Feb · Transgene Biotek - Updates
10 Feb · Transgene's novel Liver Cancer drug shows promise in latest animal studies
Jan 2010
30 Jan · Results
25 Jan · Transgene's therapeutic AIDS Vaccine achieves critical Milestone